ARCADIS NV (ARCAD.AS) Fundamental Analysis & Valuation

AMS:ARCAD • NL0006237562

28.72 EUR
-0.38 (-1.31%)
Last: Mar 11, 2026, 07:00 PM

This ARCAD.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Taking everything into account, ARCAD scores 5 out of 10 in our fundamental rating. ARCAD was compared to 34 industry peers in the Professional Services industry. ARCAD scores excellent on profitability, but there are some minor concerns on its financial health. ARCAD is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. ARCAD.AS Profitability Analysis

1.1 Basic Checks

  • In the past year ARCAD was profitable.
  • ARCAD had a positive operating cash flow in the past year.
  • In the past 5 years ARCAD has always been profitable.
  • Each year in the past 5 years ARCAD had a positive operating cash flow.
ARCAD.AS Yearly Net Income VS EBIT VS OCF VS FCFARCAD.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • With a decent Return On Assets value of 5.73%, ARCAD is doing good in the industry, outperforming 76.47% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 20.08%, ARCAD is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 11.47%, ARCAD is doing good in the industry, outperforming 70.59% of the companies in the same industry.
  • ARCAD had an Average Return On Invested Capital over the past 3 years of 11.41%. This is in line with the industry average of 11.13%.
  • The 3 year average ROIC (11.41%) for ARCAD is below the current ROIC(11.47%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.73%
ROE 20.08%
ROIC 11.47%
ROA(3y)5.4%
ROA(5y)5.15%
ROE(3y)18.28%
ROE(5y)16.89%
ROIC(3y)11.41%
ROIC(5y)10.54%
ARCAD.AS Yearly ROA, ROE, ROICARCAD.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • The Profit Margin of ARCAD (5.53%) is better than 67.65% of its industry peers.
  • In the last couple of years the Profit Margin of ARCAD has grown nicely.
  • Looking at the Operating Margin, with a value of 8.43%, ARCAD is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ARCAD has grown nicely.
Industry RankSector Rank
OM 8.43%
PM (TTM) 5.53%
GM N/A
OM growth 3Y3.65%
OM growth 5Y2.3%
PM growth 3Y8.28%
PM growth 5Y48.85%
GM growth 3YN/A
GM growth 5YN/A
ARCAD.AS Yearly Profit, Operating, Gross MarginsARCAD.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8 10

5

2. ARCAD.AS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ARCAD is creating some value.
  • The number of shares outstanding for ARCAD has been reduced compared to 1 year ago.
  • ARCAD has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ARCAD is higher compared to a year ago.
ARCAD.AS Yearly Shares OutstandingARCAD.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
ARCAD.AS Yearly Total Debt VS Total AssetsARCAD.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.30 indicates that ARCAD is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ARCAD has a Altman-Z score (2.30) which is in line with its industry peers.
  • The Debt to FCF ratio of ARCAD is 3.01, which is a good value as it means it would take ARCAD, 3.01 years of fcf income to pay off all of its debts.
  • ARCAD has a better Debt to FCF ratio (3.01) than 82.35% of its industry peers.
  • A Debt/Equity ratio of 0.80 indicates that ARCAD is somewhat dependend on debt financing.
  • ARCAD has a Debt to Equity ratio of 0.80. This is comparable to the rest of the industry: ARCAD outperforms 47.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 3.01
Altman-Z 2.3
ROIC/WACC1.7
WACC6.73%
ARCAD.AS Yearly LT Debt VS Equity VS FCFARCAD.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • ARCAD has a Current Ratio of 1.02. This is a normal value and indicates that ARCAD is financially healthy and should not expect problems in meeting its short term obligations.
  • ARCAD has a Current ratio (1.02) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.02 indicates that ARCAD should not have too much problems paying its short term obligations.
  • ARCAD has a Quick ratio of 1.02. This is comparable to the rest of the industry: ARCAD outperforms 44.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
ARCAD.AS Yearly Current Assets VS Current LiabilitesARCAD.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1

3. ARCAD.AS Growth Analysis

3.1 Past

  • The earnings per share for ARCAD have decreased strongly by -13.53% in the last year.
  • Looking at the last year, ARCAD shows a decrease in Revenue. The Revenue has decreased by -3.09% in the last year.
EPS 1Y (TTM)-13.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-21.8%
Revenue 1Y (TTM)-3.09%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%24.09%

3.2 Future

  • Based on estimates for the next years, ARCAD will show a decrease in Earnings Per Share. The EPS will decrease by -5.28% on average per year.
  • ARCAD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.52% yearly.
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%

3.3 Evolution

ARCAD.AS Yearly Revenue VS EstimatesARCAD.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
ARCAD.AS Yearly EPS VS EstimatesARCAD.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

5

4. ARCAD.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.65, ARCAD is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of ARCAD indicates a somewhat cheap valuation: ARCAD is cheaper than 67.65% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.15. ARCAD is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 16.71, which indicates a correct valuation of ARCAD.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ARCAD.
  • ARCAD is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.65
Fwd PE 16.71
ARCAD.AS Price Earnings VS Forward Price EarningsARCAD.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 73.53% of the companies in the same industry are more expensive than ARCAD, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ARCAD indicates a rather cheap valuation: ARCAD is cheaper than 88.24% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.91
EV/EBITDA 7.57
ARCAD.AS Per share dataARCAD.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ARCAD has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as ARCAD's earnings are expected to decrease with -7.26% in the coming years.
PEG (NY)1.92
PEG (5Y)N/A
EPS Next 2Y5.64%
EPS Next 3Y-7.26%

6

5. ARCAD.AS Dividend Analysis

5.1 Amount

  • ARCAD has a Yearly Dividend Yield of 3.41%.
  • Compared to an average industry Dividend Yield of 2.45, ARCAD pays a bit more dividend than its industry peers.
  • ARCAD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.41%

5.2 History

  • On average, the dividend of ARCAD grows each year by 91.86%, which is quite nice.
Dividend Growth(5Y)91.86%
Div Incr Years6
Div Non Decr Years6
ARCAD.AS Yearly Dividends per shareARCAD.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 42.79% of the earnings are spent on dividend by ARCAD. This is a bit on the high side, but may be sustainable.
DP42.79%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
ARCAD.AS Yearly Income VS Free CF VS DividendARCAD.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M
ARCAD.AS Dividend Payout.ARCAD.AS Dividend Payout, showing the Payout Ratio.ARCAD.AS Dividend Payout.PayoutRetained Earnings

ARCAD.AS Fundamentals: All Metrics, Ratios and Statistics

ARCADIS NV

AMS:ARCAD (3/11/2026, 7:00:00 PM)

28.72

-0.38 (-1.31%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-19
Earnings (Next)04-30
Inst Owners65.86%
Inst Owner ChangeN/A
Ins Owners0.46%
Ins Owner ChangeN/A
Market Cap2.60B
Revenue(TTM)3.76B
Net Income(TTM)208.00M
Analysts78.95
Price Target48.56 (69.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.41%
Yearly Dividend1.01
Dividend Growth(5Y)91.86%
DP42.79%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.16%
Min Revenue beat(2)-5.68%
Max Revenue beat(2)1.36%
Revenue beat(4)1
Avg Revenue beat(4)-16.47%
Min Revenue beat(4)-35.5%
Max Revenue beat(4)1.36%
Revenue beat(8)1
Avg Revenue beat(8)-13.89%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.97%
PT rev (3m)-18.96%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-6.06%
EPS NY rev (3m)-8.64%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-10.25%
Revenue NY rev (3m)-10.95%
Valuation
Industry RankSector Rank
PE 18.65
Fwd PE 16.71
P/S 0.69
P/FCF 6.91
P/OCF 6.48
P/B 2.51
P/tB N/A
EV/EBITDA 7.57
EPS(TTM)1.54
EY5.36%
EPS(NY)1.72
Fwd EY5.98%
FCF(TTM)4.16
FCFY14.48%
OCF(TTM)4.43
OCFY15.44%
SpS41.57
BVpS11.46
TBVpS-4.83
PEG (NY)1.92
PEG (5Y)N/A
Graham Number19.92
Profitability
Industry RankSector Rank
ROA 5.73%
ROE 20.08%
ROCE 16%
ROIC 11.47%
ROICexc 13.52%
ROICexgc 98.98%
OM 8.43%
PM (TTM) 5.53%
GM N/A
FCFM 10%
ROA(3y)5.4%
ROA(5y)5.15%
ROE(3y)18.28%
ROE(5y)16.89%
ROIC(3y)11.41%
ROIC(5y)10.54%
ROICexc(3y)13.31%
ROICexc(5y)12.46%
ROICexgc(3y)69.58%
ROICexgc(5y)59.19%
ROCE(3y)15.79%
ROCE(5y)14.57%
ROICexgc growth 3Y38.51%
ROICexgc growth 5Y19.6%
ROICexc growth 3Y18.13%
ROICexc growth 5Y2.93%
OM growth 3Y3.65%
OM growth 5Y2.3%
PM growth 3Y8.28%
PM growth 5Y48.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 3.01
Debt/EBITDA 1.86
Cap/Depr 19.08%
Cap/Sales 0.66%
Interest Coverage 4.01
Cash Conversion 89.51%
Profit Quality 180.77%
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 2.3
F-Score6
WACC6.73%
ROIC/WACC1.7
Cap/Depr(3y)24.86%
Cap/Depr(5y)27.76%
Cap/Sales(3y)0.97%
Cap/Sales(5y)1.12%
Profit Quality(3y)157.97%
Profit Quality(5y)166.97%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-21.8%
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue 1Y (TTM)-3.09%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%24.09%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%
EBIT growth 1Y-18.51%
EBIT growth 3Y11.52%
EBIT growth 5Y11.06%
EBIT Next Year40.87%
EBIT Next 3Y15.76%
EBIT Next 5Y14.66%
FCF growth 1Y23.28%
FCF growth 3Y15.52%
FCF growth 5Y-1.42%
OCF growth 1Y14.57%
OCF growth 3Y12.18%
OCF growth 5Y-1.34%

ARCADIS NV / ARCAD.AS FAQ

Can you provide the ChartMill fundamental rating for ARCADIS NV?

ChartMill assigns a fundamental rating of 5 / 10 to ARCAD.AS.


What is the valuation status for ARCAD stock?

ChartMill assigns a valuation rating of 5 / 10 to ARCADIS NV (ARCAD.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for ARCADIS NV?

ARCADIS NV (ARCAD.AS) has a profitability rating of 7 / 10.


What are the PE and PB ratios of ARCADIS NV (ARCAD.AS) stock?

The Price/Earnings (PE) ratio for ARCADIS NV (ARCAD.AS) is 18.65 and the Price/Book (PB) ratio is 2.51.


What is the financial health of ARCADIS NV (ARCAD.AS) stock?

The financial health rating of ARCADIS NV (ARCAD.AS) is 5 / 10.